Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
‘The Number One Priority Is Sustainable Access’ – AAM Chair Hoffman On Stabilizing The US Industry
Lupin US CCO Discusses 2026 Goals For Industry Association
Apr 10 2026
•
By
Dave Wallace
Lupin’s Bob Hoffman is the new AAM chair
(AAM)
More from Interviews
More from Interviews